SCHEMBL17846108

SCHEMBL17846108

O=C(O)NCC(CCCOC1CCCCO1)c1ccccc1O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
KDM4C Q9H3R0 1/20 0.39
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
SLC6A3 Q01959 2/20 0.34
RAB9A P51151 3/20 0.34
NPC1 O15118 2/20 0.34
ADORA3 P0DMS8 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
CREBBP Q92793 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
ALDH1A1 P00352 1/20 0.33
RECQL P46063 1/20 0.33
EP300 Q09472 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7306485 0.78 SLC6A3 (0.45) MEN1KMT2ASLC6A3
SCHEMBL17845984 0.77 MEN1 (0.38) MEN1KMT2AKDM4CSLC6A3RAB9A
SCHEMBL7305547 0.73 MEN1 (0.43) MEN1KMT2AHPGDSLC6A3SMN1; SMN2
SCHEMBL17846111 0.72 MEN1 (0.48) MEN1KMT2AKDM4CHPGDSLC6A3
SCHEMBL21886902 0.72 SLC6A3 (0.53) MEN1KMT2AKDM4CSLC6A3ADORA3
SCHEMBL21886901 0.71 MEN1 (0.49) MEN1KMT2AKDM4CHPGDHTT
SCHEMBL17846125 0.71 MEN1 (0.47) MEN1KMT2AKDM4CHPGDHTT
SCHEMBL9860360 0.70 MEN1 (0.54) MEN1KMT2AKDM4CHTTSLC6A3
SCHEMBL10679283 0.70 MEN1 (0.49) MEN1KMT2AKDM4CRAB9ANPC1
SCHEMBL22504269 0.69 KMT2A (0.52) MEN1KMT2AKDM4CHPGDSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233859-A1 ERK INHIBITORS Merck Sharp & Dohme Corp. (US) 2017-10-25 EP disclosed
WO-2016100051-A1 ERK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-06-23 WO disclosed